PNEUMOCOCCAL DISEASE

This study tested a new vaccine called V116 in 313 adults living with HIV to see if it can safely prevent pneumococcal disease (a serious lung infection). Participants received either the new vaccine or an existing one, and researchers monitored side effects and immune responses.…

This study tested a new vaccine (20vPnC) that protects against 20 types of pneumonia-causing bacteria. It involved 400 Chinese adults aged 50 and older who had never received a pneumonia vaccine. Researchers compared the new vaccine's safety and immune response to an existing 13-…

This study tested a new pneumococcal vaccine in 225 healthy toddlers aged 12-15 months. The goal was to see if the vaccine is safe and triggers a strong immune response. Children received either one or two doses and were monitored for side effects like redness, fever, and irritab…

This study tested a new vaccine (20vPnC) that protects against 20 types of pneumonia-causing bacteria. About 541 healthy infants in India and Taiwan received either the new vaccine or an existing one over 4 doses. Researchers checked for side effects and measured immune responses…

This study tested a new vaccine called V116 in over 1,400 adults aged 50 and older to see if it could prevent pneumococcal disease, which can cause pneumonia and other serious infections. The vaccine was compared to the current standard vaccine (PPSV23). Researchers checked how w…